Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Chiara Lanzillotta, Fabio Di Domenico, Marzia Perluigi, et al.
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 957-969
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse
Hallie Morton, Sudhir Kshirsagar, Erika Orlov, et al.
Free Radical Biology and Medicine (2021) Vol. 172, pp. 652-667
Closed Access | Times Cited: 127
Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104961-104961
Closed Access | Times Cited: 80
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
Marzia Perluigi, Fabio Di Domenico, D. Allan Butterfield
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 103-197
Closed Access | Times Cited: 75
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease
Eugenio Barone, Fabio Di Domenico, Marzia Perluigi, et al.
Free Radical Biology and Medicine (2021) Vol. 176, pp. 16-33
Open Access | Times Cited: 99
mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder
Marzia Perluigi, Fabio Di Domenico, Eugenio Barone, et al.
Free Radical Biology and Medicine (2021) Vol. 169, pp. 382-396
Open Access | Times Cited: 92
Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer’s Disease
Rishika Dhapola, Phulen Sarma, Bikash Medhi, et al.
Molecular Neurobiology (2021) Vol. 59, Iss. 1, pp. 535-555
Closed Access | Times Cited: 72
Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges
Chongyun Wu, Luoman Yang, Shu Feng, et al.
Inflammation and Regeneration (2022) Vol. 42, Iss. 1
Open Access | Times Cited: 46
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Adelaide Carrara, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 180-180
Open Access | Times Cited: 24
The Tricarboxylic Acid Cycle as a Central Regulator of the Rate of Aging: Implications for Metabolic Interventions
Jonathan M. Borkum
Advanced Biology (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 23
Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
D. Allan Butterfield, Debra Boyd‐Kimball
Antioxidants (2020) Vol. 9, Iss. 9, pp. 818-818
Open Access | Times Cited: 62
Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
Maria Assunta Potenza, Luca Sgarra, Vanessa Desantis, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1257-1257
Open Access | Times Cited: 45
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Yuyuan Yao, Zhichu Ren, Ruihan Yang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment
D. Allan Butterfield
Antioxidants (2023) Vol. 12, Iss. 2, pp. 462-462
Open Access | Times Cited: 17
Therapeutic effects of saffron and its components on neurodegenerative diseases
Sahar Golpour Hamedani, Makan Pourmasoumi, Sudiyeh Hejri Zarifi, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24334-e24334
Open Access | Times Cited: 7
Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models
Marina Trombetta-Lima, Angélica María Sabogal-Guáqueta, Amalia M. Dolga
Cell Calcium (2021) Vol. 94, pp. 102362-102362
Open Access | Times Cited: 37
Impaired Mitophagy in Neurons and Glial Cells during Aging and Age-Related Disorders
В. С. Сухоруков, Д. Н. Воронков, Т. И. Баранич, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10251-10251
Open Access | Times Cited: 34
Dysfunction of Mitochondria in Alzheimer’s Disease: ANT and VDAC Interact with Toxic Proteins and Aid to Determine the Fate of Brain Cells
Anna Atlante, Daniela Valenti, Valentina Latina, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7722-7722
Open Access | Times Cited: 27
The complex effects of miR-146a in the pathogenesis of Alzheimer’s disease
Yunfan Long, Jiajia Liu, Yu Wang, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 5, pp. 1309-1323
Open Access | Times Cited: 5
Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia
Virginie Bottero, Judith A. Potashkin
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5403-5403
Open Access | Times Cited: 40
Therapeutic strategies for ketosis induction and their potential efficacy for the treatment of acute brain injury and neurodegenerative diseases
Lucy Camberos-Luna, Lourdes Massieu
Neurochemistry International (2019) Vol. 133, pp. 104614-104614
Closed Access | Times Cited: 37
Peripheral Administration of a Cell-Penetrating MOTS-c Analogue Enhances Memory and Attenuates Aβ1–42- or LPS-Induced Memory Impairment through Inhibiting Neuroinflammation
Jinhong Jiang, Xin Chang, YaoYan Nie, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 9, pp. 1506-1518
Closed Access | Times Cited: 27
Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases
D. Allan Butterfield, Maria Favia, Iolanda Spera, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 951-951
Open Access | Times Cited: 19
The mitochondrial calcium signaling, regulation, and cellular functions: A novel target for therapeutic medicine in neurological disorders
Saeid Bagheri‐Mohammadi, Mohammad Farjami, Ali Jaafari suha, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 5, pp. 635-655
Closed Access | Times Cited: 12
Time to Change: A Systems Pharmacology Approach to Disentangle Mechanisms of Drug-Induced Mitochondrial Toxicity
Charlotte A. Hoogstraten, Jonathan J. Lyon, Jan Smeitink, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 3, pp. 463-486
Open Access | Times Cited: 11
Redox imbalance and metabolic defects in the context of Alzheimer disease
Fabio Di Domenico, Chiara Lanzillotta, Marzia Perluigi
FEBS Letters (2024)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top